Clariant

Lummus and Clariant awarded contract for one of the world's largest PDH units

Retrieved on: 
Wednesday, May 25, 2022

HOUSTON, May 25, 2022 /PRNewswire/ -- Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced it and its catalyst partner Clariant have been awarded a major contract by Fujian Meide to supply CATOFIN technology and catalysts for a new, world-scale propane dehydrogenation (PDH) unit in Fuzhou, China. Already operating one PDH unit at its Fuzhou petrochemical complex, Fujian Meide is now building one of the largest PDH units in the world and has selected the CATOFIN process and catalysts for the project's second phase. The new unit will produce 900,000 metric tons of propylene annually and is scheduled to commence operation in 2023.

Key Points: 
  • Already operating one PDH unit at its Fuzhou petrochemical complex, Fujian Meide is now building one of the largest PDH units in the world and has selected the CATOFIN process and catalysts for the project's second phase.
  • The new unit will produce 900,000 metric tons of propylene annually and is scheduled to commence operation in 2023.
  • "Our close partnership with Clariant has continued to improve CATOFIN over the years to the benefit of our customers," said Leon de Bruyn, President and Chief Executive Officer of Lummus Technology.
  • Clariant and Lummus Technology have already proven to be the right partners for us, not only with their products, but also their technical expertise."

Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, May 23, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.
  • On this news, TG Therapeutics' stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • For more information on the TG Therapeutics investigation go to: https://bespc.com/cases/TGTX
    On May 10, 2022, Coinbase reported its first quarter 2022 results.

Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, May 17, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.
  • On this news, TG Therapeutics' stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • For more information on the TG Therapeutics investigation go to: https://bespc.com/cases/TGTX
    On May 10, 2022, Coinbase reported its first quarter 2022 results.

Bragar Eagel & Squire, P.C. Is Investigating Clariant, Core Scientific, Roblox, and Agrify and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, May 2, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.
  • On this news, Core Scientifics stock fell $0.72, or 9%, to close at $6.98 on March 3, 2022, thereby injuring investors.
  • For more information on the Agrify investigation go to: https://bespc.com/cases/AGFY
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Clariant, MoneyLion, Cronos, and Agrify and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 16, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Clariant AG is investigating internal whistleblower complaints that the company has known about since September 2021, pertaining to booking issues aimed at boosting results to meet targets.
  • On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Clariant, Anavex, Embark, and Roblox and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, March 31, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Clariant AG is investigating internal whistleblower complaints that the company has known about since September 2021, pertaining to booking issues aimed at boosting results to meet targets.
  • On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.
  • For more information on the Roblox investigation go to: https://bespc.com/cases/RBLX
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Clariant, and Anavex and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, March 26, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The DOJ is investigating business practices related to CareDxs kidney testing and phlebotomy services.
  • On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
  • For more information on the Anavex investigation go to: https://bespc.com/cases/AVXL
    About Bragar Eagel & Squire, P.C.

Clariant AG ADRs Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Retrieved on: 
Tuesday, March 22, 2022

BOSTON, March 22, 2022 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Clariant AG ADR (OTC: CLZNY) for potential securities law violations.

Key Points: 
  • BOSTON, March 22, 2022 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Clariant AG ADR (OTC: CLZNY) for potential securities law violations.
  • Investors who have lost money in their Clariant AG ADR investment should contact the firm to learn more about how they might recover those losses.
  • On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.
  • Anyone who purchased Clariant AG ADR shares and has lost money may be eligible, whether or not they have sold their investment.

Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Clariant, and Anavex and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, March 21, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The DOJ is investigating business practices related to CareDxs kidney testing and phlebotomy services.
  • On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
  • For more information on the Anavex investigation go to: https://bespc.com/cases/AVXL
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Medallion, Clariant, Anavex, and Embark and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, March 15, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
  • For more information on the Embark investigation go to: https://bespc.com/cases/EMBK
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.